Diet Intervention to Promote Liver and Brain Health in Adults With Non-alcoholic Fatty Liver Disease
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 55
- 试验地点
- 2
- 主要终点
- Decrease in Liver Fat
研究概览
简要总结
People with liver disease report difficulties with attention and problem-solving skills. Diet plays an important role in the development of liver disease and/or pre-diabetes. The purpose of this study is to examine whether participation in a brief diet intervention (up to 3 weeks) can improve brain and liver health and function.
详细描述
The importance of liver function for brain and cognitive health is undeniable. Specifically, adults with chronic liver diseases such as non-alcoholic fatty liver disease (NAFLD), a factor of metabolic syndrome (MetS), experience a range of symptoms including problems with attention, problem solving skills and executive function. Importantly, diet plays a role in the development of NAFLD. The investigators propose to be the first to demonstrate that Metabolic syndrome-related brain vulnerability, in the form of elevated free cerebral glutamate, is related to hepatic triglyceride level, through experimental manipulation of liver fat and multiorgan imaging. The investigators seek to improve liver health by altering diet content in a block randomized feeding trial. The investigators selected a low-carbohydrate (<30 g/d) diet (LoCHO) to reduce liver fat and a low-calorie (LoCAL) diet as a control for weight loss. The investigators hypothesize that LoCHO diet will improve cognitive performance by improving liver health and thus, brain health. This work may provide a way to support brain function in MetS and delay cognitive decline.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Basic Science
- 盲法
- None
入排标准
- 年龄范围
- 40 Years 至 —(Adult, Older Adult)
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- •at least 40 years of age
- •English speakers
- •show a minimum of 5% hepatic triglyceride level on liver imaging
- •have not taken part in a weight loss/dietary intervention within 6 months
- •not currently adhering to a low-carbohydrate diet (e.g., Atkins, Paleo)
排除标准
- •younger than 40 years of age
- •have a history of neurological disease (e.g. stroke, seizure disorder)
- •psychiatric illness (e.g. schizophrenia, bipolar disorder)
- •harmful alcohol use (AUDIT-C score >5)
- •morbid obesity (BMI>40)
- •MRI contraindications
结局指标
主要结局
Decrease in Liver Fat
时间窗: Liver fat will be measured at baseline (week 0) and after at least 2 weeks (up to 3 weeks) on the designated diet. The liver 1H MRS scans will happen during Visit 3 (baseline) and Visit 4 (at least 2 weeks on the diet).
Hepatic triglyceride level will be assessed using liver 1H MRS.
Decrease in cerebral gluatamate
时间窗: Cerebral glutamate will be measured at baseline (week 0) and after at least 2 weeks (up to 3 weeks) on the designated diet. The brain 1H MRS scans will happen during Visit 3 (baseline) and Visit 4 (at least 2 weeks on the diet).
Cerebral glutamate levels will be measured using 1H MRS.
次要结局
未报告次要终点
研究者
Andreana P. Haley
Professor in Clinical Psychology
University of Texas at Austin
